Results 231 to 240 of about 1,277,970 (342)
From Metabolic Syndrome to Cardiovascular-Kidney-Metabolic Syndrome and Systemic Metabolic Disorder: A Call to Recognize the Progressive Multisystemic Dysfunction. [PDF]
Özyüncü N, Erol Ç.
europepmc +1 more source
Women with overweight or obesity follow intended isocaloric early and late time‐restricted eating (TRE) in a crossover trial. Shotgun plasma lipidomics reveals no significant differences between interventions, but identify pronounced lipid changes—including reductions in ceramides and phosphatidylcholines—within the early TRE.
Kristof Szekely +15 more
wiley +1 more source
Role of Metabolic Syndrome Traits on Infectious Diseases: A Mendelian Randomization Study. [PDF]
Cao S +5 more
europepmc +1 more source
The role of germline WWOX loss‐of‐function variants in oncogenesis has remained poorly characterized. This study provides the first comprehensive genetic and functional evidence that such variants promote tumorigenesis through the disruption of multiple tumor‐suppressive mechanisms.
Xiaopeng Zhang +8 more
wiley +1 more source
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women [PDF]
David P. Rose +2 more
openalex +1 more source
Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome. [PDF]
Nzobokela J +4 more
europepmc +1 more source
The mechanism of secondary cognitive impairment following AKI. When renal ischemic injury progresses to fibrosis, renal fibroblasts and damaged tubular cells secrete MDK, which circulates through the bloodstream, crosses the damaged BBB, and accumulates in the hippocampus tissue (an area crucial for learning and memory).
Li Lu +10 more
wiley +1 more source
Internalized weight stigma, metabolic syndrome, and inflammation in postmenopausal women with obesity. [PDF]
Pearl RL +12 more
europepmc +1 more source
This study identifies CD74⁺ macrophages as key drivers of synovial inflammation in osteoarthritis (OA). The flavonoid luteolin is predicted to inhibit this pathway by blocking Nuclear Factor Kappa‐light‐chain‐enhancer of Activated B cells (NF‐κB) signaling. To enhance delivery, a targeted nanoplatform (MDSPL) is developed.
Rui Peng +15 more
wiley +1 more source

